Table 4 Hepatic blood flow and pressures
From: Effects of propofol and sevoflurane on hepatic blood flow: a randomized controlled trial
|  | Propofol Group (n = 9) | Sevoflurane Group (n = 9) | Between group difference | |
|---|---|---|---|---|
Total HBF (ml.min−1) | T1 | 997 (344) | 1003 (411) | −5 [− 395–384] |
T2 | 937 (231) | 860 (318) | 77 [− 272–426] | |
T3 | 998 (264) | 943 (225) | 55 [− 252–362] | |
Portal HBF (ml.min− 1) | T1 | 760 (275) | 790 (317) | −30 [− 352–291] |
T2 | 687 (203) | 612 (218) | 75 [− 163–313] | |
T3 | 714 (210) | 704 (137) | 10 [− 234–254] | |
Arterial HBF (ml.min− 1) | T1 | 237 (150) | 212 (138) | 25 [− 130–180] |
T2 | 249 (110) | 247 (199) | 2 [−212–216] | |
T3 | 284 (101) | 239 (149) | 45 [−110–200] | |
Relative Total HBF (% of CO) | T1 | 20.0 (6.0) | 19.9 (12.1) | 0.1 [−7.4–7.6] |
T2 | 17.4 (3.4) | 15.5 (7.6) | 1.8 [−5.2–8.9] | |
T3 | 18.4 (4.1) | 17.4 (6.7) | 1.0 [−4.8–6.7] | |
Relative Portal HBF (% of CO) | T1 | 15.2 (5.2) | 15.9 (9.4) | −0.6 [−8.1–6.9] |
T2 | 12.8 (3.7) | 11.1 (5.3) | 1.6 [−3.7–7.0] | |
T3 | 13.1 (3.8) | 12.8 (3.8) | 0.3 [−3.7–4.3] | |
Relative Arterial HBF (% of CO) | T1 | 4.8 (2.8) | 4.1 (3.4) | 0.7 [−1.4–2.8] |
T2 | 4.6 (1.9) | 4.4 (3.7) | 0.2 [−3.6–4.0] | |
T3 | 5.3 (2.0) | 4.6 (3.5) | 0.7 [−2.6–4.0] | |
Portal Vein Pressure (mmHg) | T1 | 10 (6) | 9 (3) | 1 [−4–7] |
T2 | 6 (3) | 10 (4) | −4 [−7–0] | |
T3 | 8 (4) | 9 (5) | 0 [−4–3] | |
Caval Vein Pressure (mmHg) | T1 | 6 (3) | 5 (3) | 1 [−2–4] |
T2 | 5 (3) | 7 (4) | −1 [−5–2] | |
T3 | 7 (4) | 7 (3) | 0 [−5–4] | |
PI Portal Vein | T1 | 0.4 (0.2) | 0.5 (0.3) | −0.1 [−0.4–0.2] |
T2 | 0.3 (0.2) | 0.5 (0.3) | −0.2 [− 0.4–0] | |
T3 | 0.5 (0.2) | 0.5 (0.2) | 0 [−0.1–0.2] | |
PI Hepatic Artery | T1 | 1.4 (0.9) | 1.7 (0.9) | −0.3 [− 0.9–0.4] |
T2 | 1.4 (0.6) | 1.5 (0.7) | −0.1 [− 0.8–0.5] | |
T3 | 1.4 (0.7) | 1.5 (0.5) | − 0.1[− 0.7–0.6] | |